Daily Archives: April 5, 2023
WHO Report | 1 in 6 people globally affected by infertility
5 Apr, 2023 | 13:47h | UTCNews Release: 1 in 6 people globally affected by infertility – World Health Organization
Report: Infertility Prevalence Estimates, 1990–2021 – World Health Organization
Key facts: Infertility – World Health Organization
Commentaries:
Infertility affects a ‘staggering’ 1 in 6 people worldwide, WHO says – CNN
One in six people worldwide affected by infertility, WHO reports – The Guardian
Commentary on Twitter (thread – click for more)
Around 1 in 6 people is affected by infertility in their lifetime: 🆕 WHO research.
This shows an urgent need to increase access to affordable, high-quality fertility care https://t.co/od9QQ9Qjvj pic.twitter.com/R8JtezT0kZ
— World Health Organization (WHO) (@WHO) April 4, 2023
RCT | Assessing low-dose ketamine’s antidepressant & antisuicidal effects in patients with treatment-resistant depression
5 Apr, 2023 | 13:44h | UTC
Commentary on Twitter
RCT: ketamine infusion (0.5 mg/kg) is a safe and effective treatment for patients with TRD and prominent suicidal ideation vs. midazolam. Response was noted when the current depressive episode lasted for <24 months and the number of failed AD is ≤4 https://t.co/QKNy8bUKBK pic.twitter.com/GyfQp0pmpO
— P𝘧OL (@psychopharmacol) April 4, 2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
5 Apr, 2023 | 13:45h | UTC
Commentary on Twitter
Management of severe community-acquired pneumonia: @EuroRespSoc @ESICM @ESCMID @ALATorax international guidelines
➡️ evidence-based recommendations for diagnosis, empirical treatment, ABTs
➡️ current knowledge gaps
➡️ recommendations for future research
🖇️ https://t.co/qhe1wlgN9t pic.twitter.com/LMNCbauYfs— Intensive Care Medicine (@yourICM) April 4, 2023
Cohort Study | Pregnancy glucose intolerance, even below diabetes criteria, linked to increased risk of type 2 diabetes
5 Apr, 2023 | 13:42h | UTCGlucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Review | Diagnosis and treatment of acute myocarditis
5 Apr, 2023 | 13:40h | UTCDiagnosis and Treatment of Acute Myocarditis: A Review – JAMA (free for a limited period)
RCT | Endovascular treatment vs. no treatment after 6-24h in ischemic stroke patients with collateral flow on CT angiography
5 Apr, 2023 | 13:38h | UTCEndovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
5 Apr, 2023 | 13:36h | UTCCommentary: Take Your Meds – Science
Commentary on Twitter
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems https://t.co/WSyYu24Iw1 – a new review discussing how delivery systems can mitigate impediments to adherence such as frequent dosing, adverse effects and a delayed onset of action pic.twitter.com/xoSJYFo0Qs
— Nature Reviews Drug Discovery (@NatRevDrugDisc) March 28, 2023
Review | Computed tomographic angiography in coronary artery disease
5 Apr, 2023 | 13:33h | UTCComputed tomographic angiography in coronary artery disease – EuroIntervention
RCT | Enzalutamide versus standard antiandrogen therapy in hormone-sensitive prostate cancer with metastasis
5 Apr, 2023 | 13:30h | UTCTestosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
News Release: ENZAMET shows promise as prostate cancer treatment – University of Adelaide
Review | Comprehensive care of women with genetic predisposition to breast and ovarian cancer
5 Apr, 2023 | 13:32h | UTC
Review | Why is intradialytic hypotension the commonest complication of outpatient dialysis treatments?
5 Apr, 2023 | 13:28h | UTC
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019
5 Apr, 2023 | 13:27h | UTC
Adolescent sudden cardiac death: the role of underlying conditions and physical activity
5 Apr, 2023 | 13:26h | UTCSudden Cardiac Death Among Adolescents in the United Kingdom – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary on Twitter
Among the causes of SCD in adolescents, arrhythmogenic #cardiomyopathy, coronary artery anomalies & commotio cordis are more common in young athletes who die suddenly than in similarly aged sedentary individuals.
Read more on this https://t.co/VHRIiNz1hE… pic.twitter.com/N3bev3Nv8i
— JACC Journals (@JACCJournals) March 14, 2023
Updated ADAURA trial results | Adjuvant Osimertinib improves disease-free survival in resected EGFR-mutated NSCLC
5 Apr, 2023 | 13:21h | UTCNews Release: Trial Shows Significant Disease-free Survival for Patients Diagnosed With Non-small Cell Lung Cancer – Yale School of Medicine
M-A | Vaginal swab outperforms urine for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis
5 Apr, 2023 | 13:23h | UTC
M-A | The efficacy of topical prostaglandin analogs for hair loss
5 Apr, 2023 | 13:20h | UTC
SR | The effectiveness of the interventions to reduce sound levels in the ICU
5 Apr, 2023 | 13:19h | UTC
Hydroxyurea use in youths with sickle cell anemia: underused despite updated 2014 guidelines
5 Apr, 2023 | 13:16h | UTCOriginal Guideline: National Heart, Lung, and Blood Institute. Evidence-based management of sickle cell disease: expert panel report, 2014
Commentary on Twitter
Hydroxyurea prescribing in youths with sickle cell anemia insured by Medicaid modestly after the @nih_nhlbi guidelines recommended hydroxurea in 2014. Increasing hydroxyurea use may require a multifaceted approach. https://t.co/tkY0HiMvkv
— JAMA Network Open (@JAMANetworkOpen) March 24, 2023
Review | Use of cardio-pulmonary ultrasound in the neonatal intensive care unit
5 Apr, 2023 | 12:58h | UTCUse of Cardio-Pulmonary Ultrasound in the Neonatal Intensive Care Unit – Children
Review | Evaluation of the hypotensive preterm infant: evidence-based practice at the bedside?
5 Apr, 2023 | 12:55h | UTCEvaluation of the Hypotensive Preterm Infant: Evidence-Based Practice at the Bedside? – Children
Review | Respiratory management of the preterm infant: supporting evidence-based practice at the bedside
5 Apr, 2023 | 12:53h | UTC
Consensus Paper | Definition and criteria for diagnosing cesarean scar disorder
5 Apr, 2023 | 12:51h | UTCDefinition and Criteria for Diagnosing Cesarean Scar Disorder – JAMA Network Open
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
5 Apr, 2023 | 12:50h | UTC
SR | Efficacy and tolerance of second-generation antipsychotics in anorexia nervosa
5 Apr, 2023 | 12:48h | UTC
M-A | Efficacy of flash glucose monitoring in type 1 and type 2 diabetes
5 Apr, 2023 | 12:46h | UTC